Biotech faces big shortage of skilled PhDs

A new report from Investor's Business Daily says that there aren't enough PhDs coming out of American universities to fill the demand for research positions in American pharma and biotech companies. The National Sciences Foundation says that 6,368 Ph.D.s in biological sciences were awarded in 2005, up a thousand from 10 years ago. About a third of those degrees went to foreign-born students. The article cites the experiences of Amylin, which has used H-1B visas to fill many of their positions. More than half of the 500 scientists at the Burnham Institute for Medical Research are in the U.S. on a visa. And there are plenty of quotes from executives about how hard it is to fill these positions. It's the kind of story that often gets attention from researchers who are finding it hard to land a good job.

- read the CNNMoney article

Related Articles:
U.K. researchers driven out by tough regulations. Report
GSK looks abroad for more scientists as U.K. shortage grows. Report
New report claims signs of bay area brain drain. Report

Suggested Articles

Compass' CD137 agonist cleared large tumors in mice that other I-O agents had failed to treat. It's advancing the drug into phase 1 human trials.

UPMC researchers are planning clinical trials of a COVID-19 vaccine that uses pieces of the virus' spike protein to create immunity.

Treating mice with niacin increased the number of immune cells in glioblastomas, reducing tumor size and extending survival.